Toxicology, clinical testing, compliance and lab operations — insight from the LabX team.
Half of chronic-care patients don't take medications as prescribed. Objective adherence testing turns guesswork into evidence and better outcomes.
Urine is convenient; blood is the gold standard for accuracy. A practical guide to choosing the right specimen for each clinical scenario.
A negative standard screen doesn't rule out xylazine. Here's why 'Tranq' evades routine panels and how definitive blood testing detects it.
SNFs rely on labs for critical diagnostics. Six essential questions to evaluate a lab partner and ensure quality resident care.
At-home lab testing is transforming healthcare, with the market projected to grow from $7.8B in 2025 to $11.9B by 2035.
Insurance reimbursement cuts for toxicology testing compromise diagnostic accuracy and patient safety while straining laboratories.
Medication theft in nursing homes and hospice jeopardizes vulnerable patients. Statistics, causes, and how drug testing helps.
AI is revolutionizing toxicology labs through faster drug screening, predictive medication monitoring, and personalized patient care.
Small-volume blood testing rapidly detects xylazine down to 2 ng/mL — a less invasive, tamper-resistant alternative to traditional draws.
Toxicology labs navigate complex compliance while balancing regulation with medical necessity and physician relationships.